We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Technologies Could Provide Insights on the Brain Injury and Recovery Processes

By HospiMedica International staff writers
Posted on 27 May 2010
New techniques in Optogenetics will allow researchers to genetically engineer specific types of cells in brain circuits that will turn on or off in response to pulses of a specific color of light.

Researchers at Stanford University (CA, USA), Brown University (Providence, RI, USA), the University of California San Francisco (USA) and University College London (UCL; United Kingdom) have joined the forces of 10 professors and their research teams in the Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) project, which will use optogenetics to produce completely reversible "injuries" in the brains of research animals by temporarily turning off specific parts of the brain via implants that generate light. More...
Together, the team's expertise ranges from neuroscience, neurology, and psychiatry, to semiconductors, optoelectronics, statistical signal processing, machine learning, and brain modeling.

The research team hopes to develop a new model of the flow of information around the brain, and elucidate how each part generates the signals needed by other parts. It is hoped that the insights from the research would lead to the development of prosthetic computer chips that mimic and replace the computational role of injured regions of the brain. These same chips might be miniaturized versions of the implants developed in the REPAIR project, which are capable not only of reading neural-electrical signals but also of generating optical-neural signals for use by brain cells.

"There are many advantages to using optogenetics instead of drugs or lesions,” said Karl Deisseroth, Ph.D., an associate professor of bioengineering and of psychiatry and behavioral sciences at Stanford, who pioneered optogenetics. "You are in no way injuring the animals, because as soon as you turn the light off they are back to normal, and it is also a lot cheaper, easier, and more precise to use.”

"To access and truly understand the operation of brain microcircuits and their function, the team will pursue a new generation of implantable optogenetic microdevices, with the ultimate aim of achieving a clinically useful, two-way communication link with the brain,” added Arto Nurmikko, Ph.D., a professor of electrical engineering and physics at Brown.

Optogenetics is an emerging field combining optical and genetic techniques to probe neural circuits within intact mammals and other animals, at the high speeds needed to understand brain information processing. This millisecond-scale temporal precision is central to the concept of optogenetics, which allows probing the causal role of specific action potential patterns in defined cells. By analogy, traditional genetics is used to probe the causal role of specific proteins within cells, via "loss-of-function” or "gain of function” changes in these proteins, to probe how the genetic code controls development and behavior. Correspondingly, to probe the neural code, optogenetics must allow addition or deletion of precise activity patterns within specific cells in the brains of intact animals, including mammals.

Related Links:

Stanford University
Brown University
University of California San Francisco
University College London



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.